Kamada KMDA
NASDAQ KMDA
$7.85 +0.24 (+3.15%)
At close: Oct 20, 2026 · 4:00 PM EDT

Kamada (KMDA) FCF Margin (2012 - 2026)

Updated

Kamada (KMDA) reported FCF Margin of 36.73% for the quarter ended Jun 30, 2026, up 14.31 percentage points from 22.42% a year earlier and up 35.23 percentage points from the prior quarter.

Analysis

Kamada (KMDA) FCF Margin (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kamada's FCF Margin came in at 23.56%, down 5.14 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 19.58%, down 16.66 percentage points from the prior year.

  • FCF Margin has a five-year change of +1.12 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, FCF Margin came in at 36.24% in the year ended Dec 31, 2024 (+29.11 pp), 7.13% in the year ended Dec 31, 2023 (-17.89 pp), 25.03% in the year ended Dec 31, 2022 (+29.94 pp) and -4.91% in the year ended Dec 31, 2021 (-23.37 pp).
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly FCF Margin since the quarter ended Sep 30, 2024.
  • Year over year, FCF Margin gained in three of the last eight quarters, with an average year-over-year change of +1.53 percentage points.
  • The high point for year-over-year FCF Margin in five years was the quarter ended Jun 30, 2022 (a gain of 57.06 percentage points); the low point was the quarter ended Dec 31, 2021 (a drop of 60.55 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 1.51% (quarter ended Mar 31, 2026), 23.15% (quarter ended Dec 31, 2025) and 29.79% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 28.82%
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 18.33%
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 26.96%
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 6.55%
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 34.70%
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 44.00%
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 2.01%
10 Kamada 452.52 Mn 161.58 Mn 22.47 Mn 29.06%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.06%
Mar 31, 2026 -2.79%
Dec 31, 2025 10.72%
Sep 30, 2025 14.52%
Jun 30, 2025 13.42%
Mar 31, 2025 -4.50%
Dec 31, 2024 19.16%
Sep 30, 2024 48.13%
Jun 30, 2024 25.79%
Mar 31, 2024 -4.40%
Dec 31, 2023 6.69%
Sep 30, 2023 -2.13%
Jun 30, 2023 2.10%
Mar 31, 2023 -0.01%
Dec 31, 2022 54.54%
Sep 30, 2022 0.01%
Jun 30, 2022 43.28%
Mar 31, 2022 17.63%
Dec 31, 2021 -18.15%
Sep 30, 2021 -18.21%
API Access

Kamada FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=KMDA&period=max&api_key=YOUR_API_KEY